Kenneth C. Cundy - Feb 29, 2024 Form 4/A Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Scientific Officer
Signature
/s/ Kenneth C. Cundy
Stock symbol
ANEB
Transactions as of
Feb 29, 2024
Transactions value $
$0
Form type
4/A
Date filed
3/8/2024, 08:07 AM
Date Of Original Report
Mar 1, 2024
Previous filing
Dec 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +72.6K $0.00 72.6K Feb 29, 2024 Common Stock 72.6K $2.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter beginning on April 1, 2024.

Remarks:

*This Form 4 is being filed to amend the exercise price of the stock option